Epstein Secrets

banks and Trump's longtime accounting firm Mazars USA were too sweeping, or made to harass or embarrass the president." The New York Times (11/13, Rashbaum, Weiser, 18.61M) says the President "lost more than an election last week," and "when he leaves the White House in January, he will also lose the c

imeline depends on the Food and Drug Administration authorizing the emergency use of one or more vaccines — which could happen in a matter of weeks, Slaoui noted." Vaccine Hesitancy, Supply Chain Among Hurdles To Vaccine Distribution. The Washington Post (11/13, Fadulu, 14.2M) reports, "Regional coordi

o Trump's longtime accountant for eight years of the president's personal and corporate tax records in a criminal probe." The New York Times (7/15, Rashbaum, Weiser, 18.61M) reports that in the new filing, Trump's lawyers "noted that the high court's decision allowed him to raise other objections: that

a former executive at the pharmaceutical giant GlaxoSmithKline," would not be required to make such disclosures, "citing the unusual role that Dr. Slaoui was playing in the administration amid the pandemic." Resurgence Of Coronavirus Cases Threatens To Derail Economic Recovery. The New York Times (7/

banks and Trump's longtime accounting firm Mazars USA were too sweeping, or made to harass or embarrass the president." The New York Times (11/13, Rashbaum, Weiser, 18.61M) says the President "lost more than an election last week," and "when he leaves the White House in January, he will also lose the c

imeline depends on the Food and Drug Administration authorizing the emergency use of one or more vaccines — which could happen in a matter of weeks, Slaoui noted." Vaccine Hesitancy, Supply Chain Among Hurdles To Vaccine Distribution. The Washington Post (11/13, Fadulu, 14.2M) reports, "Regional coordi

banks and Trump's longtime accounting firm Mazars USA were too sweeping, or made to harass or embarrass the president." The New York Times (11/13, Rashbaum, Weiser, 18.61M) says the President "lost more than an election last week," and "when he leaves the White House in January, he will also lose the c

imeline depends on the Food and Drug Administration authorizing the emergency use of one or more vaccines — which could happen in a matter of weeks, Slaoui noted." Vaccine Hesitancy, Supply Chain Among Hurdles To Vaccine Distribution. The Washington Post (11/13, Fadulu, 14.2M) reports, "Regional coordi